Product Name | MF | CAS | Details |
---|
1-Ethyl-3-hydrazinylidene-2,3-dihydro-1H-indol-2-one | C10H11N3O | 62295-16-3 | Details |
Taluprost acid | C22H28F2O5 | 209860-88-8 | Details |
2-Fluoropyridine-5-carboxaldehyde | C6H4FNO | 677728-92-6 | Details |
4-(Cyclohexyloxy)aniline hydrochloride | C12H17NO.ClH | 105971-50-4 | Details |
6-Oxo-1,6-dihydro-2,4'-bipyridine-5-carboxylic acid | C11H8N2O3 | 54108-41-7 | Details |
3-[3,5-Dimethyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-4-yl]propanoic acid | C13H16N4O3 | 1170850-14-2 | Details |
tert-Butylhydroquinone | C10H14O2 | 1948-33-0 | Details |
tert-Butyl 9-oxo-6-azaspiro[3.5]nonane-6-carboxylate | C13H21NO3 | 1159982-50-9 | Details |
5-Chloro-3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole | C10H9ClN2O3 | 26903-90-2 | Details |
N-[(2-Fluorophenyl)methyl]-1H-pyrazol-4-amine | C10H10FN3 | 1156177-23-9 | Details |
4-Ethoxy-2,3-dimethylbenzene-1-sulfonyl chloride | C10H13ClO3S | 1094296-27-1 | Details |
[6-(Trifluoromethyl)morpholin-2-yl]methanol | C6H10F3NO2 | 2287332-16-3 | Details |
Vasostatin I / prepro-Chromogranin A (19-94) (Human) - I-125 Labeled | Details |
Isochroman-4-one | C9H8O2 | 20924-56-5 | Details |
7-Bromo-3-methyl-2,3-dihydro-1H-indol-2-one | C9H8BrNO | 1368588-54-8 | Details |
CD1b antibody | Details |
RTN2 antibody | Details |
Detanonoate | C4H13N5O2 | 146724-94-9 | Details |
4-Phenyl-5-(piperidin-1-yl)-4H-1,2,4-triazole-3-thiol | C13H16N4S | 92110-77-5 | Details |
2'-Deoxy-5'-O-DMT-N6-isobutyryladenosine 3'-CE phosphoramidite | C44H54N7O7P | Details |
6-chloro-5-nitropyridin-2-ol | C5H3ClN2O3 | 198268-98-3 | Details |
2-Phenylethylthiourea | C9H12N2S | 6815-00-5 | Details |
[2-amino-1-(thiophen-2-yl)ethyl]dimethylamine | C8H14N2S | 790263-41-1 | Details |
Cytochrome b5A antibody | Details |
H-VQIVYKPVDLSKVTSK-OH | Details |
6-Amino-1-(2'-deoxy-beta-D-ribofuranosyl)-4-methoxy-1H- pyrazolo[3,4-d]pyrimidine | Details |
(S)-tert-Butyl 3-bromopyrrolidine-1-carboxylate | C9H16BrNO2 | 569660-89-5 | Details |
β-Hydroxy thyroxine | C15H11I4NO5 | 107849-54-7 | Details |
4-(Dimethylamino)pyridine-2-carboxylic acid | C8H10N2O2 | 890092-04-3 | Details |
MDFIC antibody | Details |
Obtusifolin | C16H12O5 | 477-85-0 | Details |
2-Amino-N-(4-pyridinylmethyl)acetamide hydrochloride | C8H12ClN3O | 1220018-62-1 | Details |
3-Methoxy-4,5-methylenedioxybenzaldehyde | C9H8O4 | 5780-07-4 | Details |
Myristicin | C11H12O3 | 607-91-0 | Details |
5-Azido- 5- deoxy- 1, 2- O-isopropylidene -beta- D- talofuranose, | Details |
TC 2559 Fumarate | C20H26N2O9 | 212332-35-9 | Details |
2-Bromo-5-(tert-butoxy)pyrazine | C8H11BrN2O | 1159816-36-0 | Details |
1-(Cyclopropylcarbonyl)-1,2,3,4-tetrahydroquinolin-6-amine | C13H16N2O | 927966-09-4 | Details |
Bromoacetic-1-13C acid | C2H3BrO2 | 57858-24-9 | Details |
1-[(3-Bromophenyl)methyl]cyclopropan-1-amine | C10H12BrN | 1249810-91-0 | Details |
1-(3-Bromophenyl)thiourea | C7H7BrN2S | 21327-14-0 | Details |
N-Methoxy-N-methylacetamide | C4H9NO2 | 78191-00-1 | Details |
Noradrenaline ELISA Kit | Details |
3-(Methylaminomethyl)tetrahydropyran | C7H15NO | 7179-97-7 | Details |
2-(5-Chloro-1,3,4-thiadiazol-2-yl)pyridine | C7H4ClN3S | 76686-93-6 | Details |
4-(Methoxymethyl)-2-(2,2,2-trifluoroethyl)-1,3-thiazole-5-carboxylic acid | C8H8F3NO3S | 1601116-04-4 | Details |
Velutinam | C17H13NO4 | 146428-62-8 | Details |
LckBP1 antibody | Details |
2,2-Difluoroethanol | C2H4F2O | 359-13-7 | Details |
2-[1-(Difluoromethyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetic acid | C8H10F2N2O2 | 1221724-52-2 | Details |
NAT13 antibody | Details |
7-Methylidene-1,4-dioxaspiro[4.5]decane | C9H14O2 | 104598-81-4 | Details |
Oritavancin | C86H97Cl3N10O26 | 171099-57-3 | Details |
VU 0357017 hydrochloride | C18H28ClN3O3 | 1135242-13-5 | Details |
3-Thien-2-yl-1H-pyrazole-4-carbaldehyde | C8H6N2OS | 26033-27-2 | Details |
Transglutaminase 2 antibody | Details |
WDHD1 antibody | Details |
3-(5-Phenyl-2H-1,2,3,4-tetrazol-2-yl)propan-1-ol | C10H12N4O | 1153022-33-3 | Details |
1-(2-Methoxyphenyl)cyclobutane-1-carboxylic acid | C12H14O3 | 74205-38-2 | Details |
3,4-dibromo-2,5-dimethylthiophene | C6H6Br2S | 39129-54-9 | Details |
Methyl 1-(difluoromethyl)-2-oxo-1,2-dihydropyridine-4-carboxylate | C8H7F2NO3 | 899452-29-0 | Details |
H-VPQTPLHTSR^-OH | Details |
5-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole hydrochloride | C6H8ClF3N2 | 1803604-92-3 | Details |
Scleroglucan | 39464-87-4 | Details |
8-(Difluoromethoxy)-1,2,3,4-tetrahydroquinoline | C10H11F2NO | 953735-66-5 | Details |
{4-[(4-Methylphenyl)methyl]morpholin-2-yl}methanamine | C13H20N2O | 1017114-89-4 | Details |
4-(2-Chlorophenyl)piperidin-4-ol hydrochloride | C11H15Cl2NO | 860228-33-7 | Details |
3-[2-(Aminomethyl)-1H-imidazol-4-yl]benzonitrile dihydrochloride | C11H11ClN4 | 1421601-94-6 | Details |
1-(3,4-Dimethylphenyl)-1H-imidazole-2-thiol | C11H12N2S | 851207-77-7 | Details |
Hydrochlorothiazide-d2 | C7H8ClN3O4S2 | 1219798-89-6 | Details |
1-(4-Bromo-2-chlorophenoxymethyl)-1H-pyrazole-3-carboxylic acid | C11H8BrClN2O3 | 1001500-72-6 | Details |
2-Bromo-4-(chloromethyl)-1-methoxybenzene | C8H8BrClO | 701-94-0 | Details |
H-SCSSCPLSKILLARL-OH | Details |
Methyl 2-(1,4-diazepan-1-yl)pyridine-4-carboxylate hydrochloride | C12H18ClN3O2 | 1235439-20-9 | Details |
3-Methyl-2-[(thien-2-ylcarbonyl)amino]butanoic acid | C10H13NO3S | 854007-21-9 | Details |
RGS20 Blocking Peptide | Details |
RIPX antibody | Details |
NEK9 antibody (Thr210) | Details |
2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-(thiophen-3-yl)acetic acid | C21H17NO4S | 372143-96-9 | Details |
2-(4-Methylphenoxy)aniline hydrochloride | C13H14ClNO | 100712-95-6 | Details |
[4-(Trifluoromethyl)piperidin-4-yl]methanol hydrochloride | C7H13ClF3NO | 2126177-46-4 | Details |
1-Methanesulfinyloctane | C9H20OS | 3079-27-4 | Details |
2-(5-Methyl-1H-pyrazol-4-yl)aniline | C10H11N3 | 114554-24-4 | Details |
3-Ethoxycyclobutan-1-ol | C6H12O2 | 78119-92-3 | Details |
4-(Oxan-4-yl)-2-(piperidin-4-yl)pyrimidine dihydrochloride | 2059942-36-6 | Details |
6-Bromo-5-methyl-1,2,3,4-tetrahydroquinoline | C10H12BrN | 1782432-98-7 | Details |
HAX1 antibody (biotin) | Details |
Methyl 1-(azetidin-3-yl)-5-oxopyrrolidine-3-carboxylate hydrochloride | 2361634-21-9 | Details |
(2S)-2-({2-Azabicyclo[2.2.1]heptane-2-carbonyl}amino)propanoic acid | C10H16N2O3 | 1485623-74-2 | Details |
(1-Cyclobutylcyclobutyl)methanamine hydrochloride | C9H18ClN | 1909326-44-8 | Details |
8-Bromo-[1,2,4]triazolo[1,5-a]pyridine-2-carboxylic acid | C7H4BrN3O2 | 1159813-05-4 | Details |
(3-Chloropropyl)-trimethylammonium chloride | C6H15Cl2N | 1936-95-4 | Details |
4-[({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2-hydroxybenzoic acid | C23H19NO5 | 2230799-79-6 | Details |
H-GPTHLFQPSLVLDMAKVLLD-OH | Details |
rac-2-[(1R,2R)-2-Benzylcyclopropyl]acetic acid | C12H14O2 | 2138272-78-1 | Details |
MAP6 Blocking Peptide | Details |
Methyl 2-amino-3-tert-butylbenzoate | C12H17NO2 | 1343059-55-1 | Details |
H-AEIEYLEK-OH | Details |
Methyl 2-(3-hydroxyphenyl)-2-(methylamino)acetate | C10H13NO3 | 1218632-01-9 | Details |
Kv7.1 antibody | Details |
Product Total: Product Page: | ||||
608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 |